School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Bum-Yong Kang PhD

  • Department of Pediatrics
    Assistant Professor
  • (404) 727-1212
  • bum-yong.kang@emory.edu
Head shot of Bum-Yong Kang

Overview

Bum-Yong Kang, Ph.D. is an Assistant Professor of Medicine and Principle Investigator (PI) at Emory Universitys Department of Medicine in the Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine. In 2010, he was first awarded research funding as an independent PI from the Childrens Center for Endothelial Biology. In January 2013, Dr. Kang received the National Scientist Development Grant from the American Heart Association, which is currently ongoing.

For more than 10 years, Dr. Kang has extensively trained in a number of academic research areas, including molecular population genetics, functional genomics using microarray and proteomic analysis, and microRNA analysis. Through two different institutional postdoctoral trainings, Dr. Kang became an expert data analyst on molecular functional genomics employing bioinformatic techniques. One major research area is molecular population genetics in which Dr. Kang trained and received his Ph.D. degree in 2002 from Seoul National University, South Korea. Another research area is functional genomics using microarray and proteomics as postdoctoral fellowship trainings in the Department of Biology at Dalhousie University, Canada from 2004-2005 and in the Department of Medicine at University of Arkansas for Medical Sciences (UAMS), U.S.A. from 2006-2009 until he was recruited to Emory University in 2009. Since 2009, Dr. Kang has intensively investigated novel approach microRNA analysis in pathogenesis of pulmonary hypertension (PH), leading not only to successful intra-institutional collaboration but also to research funding to elucidate the role of microRNA of human diseases.

Currently, Dr. Kangs research career focuses on the examination of the mechanisms of pulmonary hypertension with sickle cell disease. Early in his research career and while still a postdoctoral fellow in UAMS he made several sentinel findings of the role of LOX-1 in hypertension and atherosclerosis. After moving to Emory in 2009, his research is extended from heart to lungs, and then he became interested in the ET-1 signaling pathway and its role in PH. Most recently, he has extended his novel work on pulmonary vascular biology to the field of hypoxia-induced PH and sickle cell disease with PH (SCD-PH). His work employs novel animal models of human pulmonary vascular disease to study the role of PPAR in the development of PH. His most recent research career focuses on exploring how PPAR activation regulates microRNAs that modulate hypoxia-induced ET-1 signaling in the pathogenesis of PH.

Dr. Kangs long-term research goal is to create his own model in the pathogenesis of SCD-PH; how does pulmonary vascular remodeling generate in the pulmonary vasculature? To elucidate this question, this model will use integratedOMICS data: functional genomics, proteomics, microRNAs, and metabolomics analysis, lead not only to identifying innovative approaches to the treatment of pulmonary vascular disease, but also to clarifying mechanisms by which PPAR can favorably modulate the expression of proliferative mediators in SCD-PH.

Academic Appointment

  • Assistant Professor of Medicine, Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Emory University School of Medicine
  • Principle Investigator, Emory University

Education

Degrees

  • PhD from Seoul National University

Research

Publications

  • ETV2/ER71 regulates hematovascular lineage generation and vascularization through an H3K9 demethylase, KDM4A.
    iScience Volume: 28 Page(s): 111538
    01/17/2025 Authors: Kim MS; Lee R; Lee DH; Song H; Ha T; Kim JK; Kang B-Y; Agger K; Helin K; Shin D
  • Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in cystic fibrosis.
    Front Immunol Volume: 16 Page(s): 1486784
    01/01/2025 Authors: Ozuna H; Bojja D; Partida-Sanchez S; Hall-Stoodley L; Amer A; Britt RD; Sheikh S; Frank DA; Wang W; Kang B-Y
  • PPAR/ETV2 axis regulates endothelial-to-mesenchymal transition in pulmonary hypertension.
    Pulm Circ Volume: 14 Page(s): e12448
    10/01/2024 Authors: Lee DH; Kim M; Chang SS; Lee R; Jang AJ; Kim J; Ma J; Passineau MJ; Benza RL; Karmouty-Quintana H
  • 3'UTR shortening of HAS2 promotes hyaluronan hyper-synthesis and bioenergetic dysfunction in pulmonary hypertension.
    Matrix Biol Volume: 111 Page(s): 53 - 75
    08/01/2022 Authors: Tseng V; Collum SD; Allawzi A; Crotty K; Yeligar S; Trammell A; Ryan Smith M; Kang B-Y; Sutliff RL; Ingram JL
  • Circular RNA Expression in the Lungs of Sickle Cell Disease Mice
    Volume: 35
    05/01/2021 Authors: Sueblinvong V; Chang S; Park C; Benza R; Archer D; Sutliff R; Hart C; Kang B-Y
  • PPAR increases HUWE1 to attenuate NF-B/p65 and sickle cell disease with pulmonary hypertension.
    Blood Adv Volume: 5 Page(s): 399 - 413
    01/26/2021 Authors: Jang AJ; Chang SS; Park C; Lee C-M; Benza RL; Passineau MJ; Ma J; Archer DR; Sutliff RL; Hart CM
  • MicroRNA-98 reduces nerve growth factor expression in nicotine-induced airway remodeling.
    J Biol Chem Volume: 295 Page(s): 18051 - 18064
    12/25/2020 Authors: Wongtrakool C; Ko J; Jang AJ; Grooms K; Chang S; Sylber C; Kosmider B; Bahmed K; Blackburn MR; Sutliff RL
  • MicroRNA-98 reduces nerve growth factor expression in nicotine-induced airway remodeling.
    J Biol Chem Volume: 295 Page(s): 18051 - 18064
    12/25/2020 Authors: Wongtrakool C; Ko J; Jang AJ; Grooms K; Chang S; Sylber C; Kosmider B; Bahmed K; Blackburn MR; Sutliff RL
  • HIV X4 Variants Increase Arachidonate 5-Lipoxygenase in the Pulmonary Microenvironment and are associated with Pulmonary Arterial Hypertension.
    Sci Rep Volume: 10 Page(s): 11696
    07/16/2020 Authors: Almodovar S; Wade BE; Porter KM; Smith JM; Lopez-Astacio RA; Bijli K; Kang B-Y; Cribbs SK; Guidot DM; Molehin D
  • Integrative Analysis of Long Non-Coding RNAs and mRNAs in Lungs of Sickle Cell Mice
    Volume: 34
    04/01/2020 Authors: Kang B-Y; Chang S; Park C; Archer D; Sutliff R; Hart C
  • PPAR gamma/ETV2 Regulated Endothelial-to-Mesenchymal Transition in the Hypoxia/Sugen Rat Model of Pulmonary Hypertension
    Volume: 33
    04/01/2019 Authors: Kang B-Y; Lee DH; Kim J; Chang SS; Ma J; Sutliff RL; Hart CM; Park C
  • Alterations in Sirt1 Attenuate Host Defense to Pneumococcal Infection in Sickle Cell Disease
    Volume: 33
    04/01/2019 Authors: Bedi B; Kang B-Y; Hart CM; Sadikot RT
  • PPAR Regulates Mitochondrial Structure and Function and Human Pulmonary Artery Smooth Muscle Cell Proliferation.
    Am J Respir Cell Mol Biol Volume: 58 Page(s): 648 - 657
    05/01/2018 Authors: Yeligar SM; Kang B-Y; Bijli KM; Kleinhenz JM; Murphy TC; Torres G; San Martin A; Sutliff RL; Hart CM
  • Peroxisome proliferator-activated receptor- enhances human pulmonary artery smooth muscle cell apoptosis through microRNA-21 and programmed cell death 4.
    Am J Physiol Lung Cell Mol Physiol Volume: 313 Page(s): L371 - L383
    08/01/2017 Authors: Green DE; Murphy TC; Kang B-Y; Bedi B; Yuan Z; Sadikot RT; Hart CM
  • Hypoxia inhibits expression and function of mitochondrial thioredoxin 2 to promote pulmonary hypertension.
    Am J Physiol Lung Cell Mol Physiol Volume: 312 Page(s): L599 - L608
    05/01/2017 Authors: Adesina SE; Wade BE; Bijli KM; Kang B-Y; Williams CR; Ma J; Go Y-M; Hart CM; Sutliff RL
  • PPAR attenuates hypoxia-induced hypertrophic transcriptional pathways in the heart.
    Pulm Circ Volume: 7 Page(s): 98 - 107
    03/01/2017 Authors: Chaudhry A; Carthan KA; Kang B-Y; Calvert J; Sutliff RL; Michael Hart C
  • Peroxisome Proliferator-Activated Receptor Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung.
    Am J Respir Cell Mol Biol Volume: 56 Page(s): 131 - 144
    01/01/2017 Authors: Kang B-Y; Park K; Kleinhenz JM; Murphy TC; Sutliff RL; Archer D; Hart CM
  • Proline-rich tyrosine kinase 2 downregulates peroxisome proliferator-activated receptor gamma to promote hypoxia-induced pulmonary artery smooth muscle cell proliferation.
    Pulm Circ Volume: 6 Page(s): 202 - 210
    06/01/2016 Authors: Bijli KM; Kang B-Y; Sutliff RL; Hart CM
  • Peroxisome Proliferator-Activated Receptor and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.
    Am J Respir Cell Mol Biol Volume: 54 Page(s): 136 - 146
    01/01/2016 Authors: Kang B-Y; Park KK; Kleinhenz JM; Murphy TC; Green DE; Bijli KM; Yeligar SM; Carthan KA; Searles CD; Sutliff RL
  • Hemolysis Reduces Huwe1 Through Ppar gamma Downregulation In Sickle Cell Disease-Pulmonary Hypertension
    Volume: 193
    01/01/2016 Authors: Kang B-Y; Kleinhenz JM; Murphy TC; Sutliff RL; Archer D; Hart CM
  • Targeting mitochondrial reactive oxygen species to modulate hypoxia-induced pulmonary hypertension.
    Free Radic Biol Med Volume: 87 Page(s): 36 - 47
    10/01/2015 Authors: Adesina SE; Kang B-Y; Bijli KM; Ma J; Cheng J; Murphy TC; Michael Hart C; Sutliff RL
  • Low-Dose Cadmium Causes Metabolic and Genetic Dysregulation Associated With Fatty Liver Disease in Mice.
    Toxicol Sci Volume: 147 Page(s): 524 - 534
    10/01/2015 Authors: Go Y-M; Sutliff RL; Chandler JD; Khalidur R; Kang B-Y; Anania FA; Orr M; Hao L; Fowler BA; Jones DP
  • Peroxisome proliferator-activated receptor gamma depletion stimulates Nox4 expression and human pulmonary artery smooth muscle cell proliferation.
    Free Radic Biol Med Volume: 80 Page(s): 111 - 120
    03/01/2015 Authors: Bijli KM; Kleinhenz JM; Murphy TC; Kang B-Y; Adesina SE; Sutliff RL; Hart CM
  • PPAR GAMMA LIGANDS ATTENUATE HYPOXIA-INDUCED PROLIFERATION IN VASCULAR SMOOTH MUSCLE CELLS THROUGH MODULATION OF MIRNA-21
    Volume: 63 Page(s): 449 - 450
    02/01/2015 Authors: Green DE; Murphy T; Kang B; Searles C; Hart CM
  • PPAR Ligands Attenuate Hypoxia-Induced Proliferation in Human Pulmonary Artery Smooth Muscle Cells through Modulation of MicroRNA-21.
    PLoS One Volume: 10 Page(s): e0133391
    01/01/2015 Authors: Green DE; Murphy TC; Kang B-Y; Searles CD; Hart CM
  • Proline-rich tyrosine kinase regulates NF-kappa B and PPAR gamma to promote hypoxia-induced proliferative phenotype of human pulmonary artery smooth muscle cells
    FASEB JOURNAL Volume: 28
    04/01/2014 Authors: Bijli K; Kang B-Y; Adesina S; Murphy T; Kleinhenz J; Hart C
  • microRNA-98 negatively regulates nicotine-induced nerve growth factor expression in primary mouse lung fibroblasts
    FASEB JOURNAL Volume: 28
    04/01/2014 Authors: Kang B-Y; Grooms K; Sutliff R; Hart CM; Wongtrakool C
  • Chronic hypoxia promotes pulmonary artery endothelial cell proliferation through H2O2-induced 5-lipoxygenase.
    PLoS One Volume: 9 Page(s): e98532
    01/01/2014 Authors: Porter KM; Kang B-Y; Adesina SE; Murphy TC; Hart CM; Sutliff RL
  • Hemin-Induced miR-27a Reduces PPAR gamma Expression in Sickle Cell Disease with Pulmonary Hypertension
    Volume: 27
    04/01/2013 Authors: Kang B-Y; Park KK; Tan F; Ghosh S; Sutliff RL; Ofori-Acquah SF; Hart CM
  • Loss of PPAR gamma promotes NF-kappa B activation, Nox4 induction, and proliferation of human pulmonary artery smooth muscle cells
    Volume: 27
    04/01/2013 Authors: Bijli KM; Kang B-Y; Murphy T; Hart CM
  • Hypoxia mediates mutual repression between microRNA-27a and PPAR in the pulmonary vasculature.
    PLoS One Volume: 8 Page(s): e79503
    01/01/2013 Authors: Kang B-Y; Park KK; Green DE; Bijli KM; Searles CD; Sutliff RL; Hart CM
  • The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation.
    Am J Respir Cell Mol Biol Volume: 47 Page(s): 718 - 726
    11/01/2012 Authors: Green DE; Murphy TC; Kang B-Y; Kleinhenz JM; Szyndralewiez C; Page P; Sutliff RL; Hart CM
  • Peroxisome proliferator-activated receptor gamma (PPAR) regulates thrombospondin-1 and Nox4 expression in hypoxia-induced human pulmonary artery smooth muscle cell proliferation.
    Pulm Circ Volume: 2 Page(s): 483 - 491
    10/01/2012 Authors: Green DE; Kang B-Y; Murphy TC; Hart CM
  • MicroRNA-27a and PPAR gamma regulate endothelin signaling in sickle cell disease-related pulmonary hypertension
    Volume: 26
    04/01/2012 Authors: Kang B-Y; Park KK; Tan F; Sutliff RL; Ofori-Acquah SF; Hart CM
  • MicroRNA-98 negatively regulates hypoxia-induced endothelin-1 expression in human pulmonary artery endothelial cells
    Volume: 26
    04/01/2012 Authors: Kang B-Y; Park KK; Sutliff RL; Hart CM
  • Dual AAV/IL-10 Plus STAT3 Anti-Inflammatory Gene Delivery Lowers Atherosclerosis in LDLR KO Mice, but without Increased Benefit.
    Int J Vasc Med Volume: 2012 Page(s): 524235
    01/01/2012 Authors: Cao M; Khan JA; Kang B-Y; Mehta JL; Hermonat PL
  • The PPAR ligand rosiglitazone attenuates hypoxia-induced endothelin signaling in vitro and in vivo.
    Am J Physiol Lung Cell Mol Physiol Volume: 301 Page(s): L881 - L891
    12/01/2011 Authors: Kang B-Y; Kleinhenz JM; Murphy TC; Hart CM
  • Systemic human Netrin-1 gene delivery by adeno-associated virus type 8 alters leukocyte accumulation and atherogenesis in vivo.
    Gene Ther Volume: 18 Page(s): 437 - 444
    05/01/2011 Authors: Khan JA; Cao M; Kang BY; Liu Y; Mehta JL; Hermonat PL
  • MODULATION OF CARDIAC REMODELING AFTER CHRONIC ISCHEMIA BY LECTIN- LIKE OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR-1 DELETION
    Volume: 57 Page(s): E1095 - E1095
    04/05/2011 Authors: Lu J; Wang W; Muniyappa H; Wang X; Mitra S; Long B; Das KC; Kang B-Y; Marwali MR; Hu C
  • The PPAR gamma Ligand, Rosiglitazone Attenuates Hypoxia-Induced Endothelin Signaling in vitro and in vivo
    FASEB JOURNAL Volume: 25
    04/01/2011 Authors: Kang B-Y; Ritzenthaler JD; Hart MC
  • A high-density genetic linkage map of a black spruce (Picea mariana) red spruce (Picea rubens) interspecific hybrid.
    Genome Volume: 54 Page(s): 128 - 143
    02/01/2011 Authors: Kang B-Y; Major JE; Rajora OP
  • Oxidized LDL receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer.
    PLoS One Volume: 6 Page(s): e20277
    01/01/2011 Authors: Khaidakov M; Mitra S; Kang B-Y; Wang X; Kadlubar S; Novelli G; Raj V; Winters M; Carter WC; Mehta JL
  • AAV/hSTAT3-gene delivery lowers aortic inflammatory cell infiltration in LDLR KO mice on high cholesterol.
    Atherosclerosis Volume: 213 Page(s): 59 - 66
    11/01/2010 Authors: Khan JA; Cao M; Kang B-Y; Liu Y; Mehta JL; Hermonat PL
  • Near-saturated and complete genetic linkage map of black spruce (Picea mariana).
    BMC Genomics Volume: 11 Page(s): 515
    09/24/2010 Authors: Kang B-Y; Mann IK; Major JE; Rajora OP
  • Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance.
    Circ Cardiovasc Imaging Volume: 3 Page(s): 464 - 472
    07/01/2010 Authors: Li D; Patel AR; Klibanov AL; Kramer CM; Ruiz M; Kang B-Y; Mehta JL; Beller GA; Glover DK; Meyer CH
  • Oxidative stress modulates PPAR gamma in vascular endothelial cells.
    Free Radic Biol Med Volume: 48 Page(s): 1618 - 1625
    06/15/2010 Authors: Blanquicett C; Kang B-Y; Ritzenthaler JD; Jones DP; Hart CM
  • Genomics of cardiac remodeling in angiotensin II-treated wild-type and LOX-1-deficient mice.
    Physiol Genomics Volume: 42 Page(s): 42 - 54
    06/01/2010 Authors: Kang B-Y; Hu C; Ryu S; Khan JA; Biancolella M; Prayaga S; Seung K-B; Novelli G; Mehta P; Mehta JL
  • PPARgamma as a potential therapeutic target in pulmonary hypertension.
    Ther Adv Respir Dis Volume: 4 Page(s): 143 - 160
    06/01/2010 Authors: Sutliff RL; Kang B-Y; Hart CM
  • Curcumin Reduces Angiotensin II-mediated Cardiomyocyte Growth via LOX-1 Inhibition (vol 55, pg 176, 2010)
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY Volume: 55 Page(s): 416 - 424
    04/01/2010 Authors: Kang B-Y; Khan JA; Ryu S; Shekhar R; Seung K-B; Mehta JL
  • Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition.
    J Cardiovasc Pharmacol Volume: 55 Page(s): 417 - 424
    04/01/2010 Authors: Kang B-Y; Khan JA; Ryu S; Shekhar R; Seung K-B; Mehta JL
  • Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition.
    J Cardiovasc Pharmacol Volume: 55 Page(s): 176 - 183
    02/01/2010 Authors: Kang B-Y; Khan JA; Ryu S; Shekhar R; Seung K-B; Mehta JL
  • Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
    J Cardiovasc Pharmacol Ther Volume: 14 Page(s): 283 - 291
    12/01/2009 Authors: Kang B-Y; Mehta JL
  • Cardiac hypertrophy during hypercholesterolemia and its amelioration with rosuvastatin and amlodipine.
    J Cardiovasc Pharmacol Volume: 54 Page(s): 327 - 334
    10/01/2009 Authors: Kang B-Y; Wang W; Palade P; Sharma SG; Mehta JL
  • Statins and angiogenesis: is it about connections?
    Biochem Biophys Res Commun Volume: 387 Page(s): 543 - 547
    09/25/2009 Authors: Khaidakov M; Wang W; Khan JA; Kang B-Y; Hermonat PL; Mehta JL
  • Deletion of LOX-1 attenuates renal injury following angiotensin II infusion.
    Kidney Int Volume: 76 Page(s): 521 - 527
    09/01/2009 Authors: Hu C; Kang B-Y; Megyesi J; Kaushal GP; Safirstein RL; Mehta JL
  • Cervical cancer isolate PT3, super-permissive for adeno-associated virus replication, over-expresses DNA polymerase delta, PCNA, RFC and RPA.
    BMC Microbiol Volume: 9 Page(s): 79
    04/23/2009 Authors: Kang BY; You H; Bandyopadhyay S; Agrawal N; Melchert RB; Basnakian AG; Liu Y; Hermonat PL
  • LOX-1 dependent overexpression of immunoglobulins in cardiomyocytes in response to angiotensin II.
    Biochem Biophys Res Commun Volume: 379 Page(s): 395 - 399
    02/06/2009 Authors: Kang B-Y; Hu C; Prayaga S; Khaidakov M; Sawamura T; Seung K-B; Mehta JL
  • Differential gene expression profiling in HELLP syndrome placentas.
    Reprod Sci Volume: 15 Page(s): 285 - 294
    04/01/2008 Authors: Kang B-Y; Tsoi S; Zhu S; Su S; Kay HH
  • An AFLP-based linkage map of Japanese red pine (Pinus densiflora) using haploid DNA samples of megagametophytes from a single maternal tree.
    Mol Cells Volume: 20 Page(s): 201 - 209
    10/31/2005 Authors: Kim Y-Y; Choi H-S; Kang B-Y
  • Association between apolipoprotein A2 MspI polymorphism and hypertriglyceridemia in Koreans.
    Hum Biol Volume: 70 Page(s): 41 - 46
    02/01/1998 Authors: Hong SH; Kang BY; Park WH; Kim JQ; Lee CC
  • Genetic variation of the angiotensin-converting enzyme gene: increased frequency of the insertion allele in Koreans.
    Clin Genet Volume: 51 Page(s): 35 - 38
    01/01/1997 Authors: Hong SH; Kang BY; Park WH; Kim JQ; Lee CC
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements